Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation
Satish Shanbhag1,2, Mitchell R Smith1, Robert VB Emmons21Department of Medical Oncology, Fox Chase Cancer Center, 2Division of Bone Marrow Transplantation, Temple University, Philadelphia, PA, USAAbstract: Mantle cell lymphoma (MCL) is a type of non-Hodgkins lymphoma (NHL) associated with poor progr...
Guardado en:
Autores principales: | Satish Shanbhag, Mitchell R Smith, Robert VB Emmons |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d68f3bca3b8a4460ae9101b261536de9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Some aspects of allogeneic stem cell transplantation in patients with myelodysplastic syndrome: advances and controversy
por: Blau O, et al.
Publicado: (2014) -
Hematopoietic stem cell transplantation for the management of follicular lymphoma
por: Chitra Hosing
Publicado: (2010) -
Hematopoietic stem cell transplantation
por: Eleftheria Hatzimichael, et al.
Publicado: (2010) -
Treatment of systemic sclerosis: potential role for stem cell transplantation
por: Wen Xiong, et al.
Publicado: (2009) -
Cat amniotic membrane multipotent cells are nontumorigenic and are safe for use in cell transplantation
por: Vidane AS, et al.
Publicado: (2014)